Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
8.
Asian Pac J Cancer Prev ; 15(22): 9785-90, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25520105

RESUMEN

BACKGROUND: The aim of this study is to examine the association of urinary cesium with breast cancer risk. MATERIALS AND METHODS: We collected survey data and urine specimens from 240 women with incident invasive breast cancer before their treatment and 246 age-matched female controls between October 2009 and July 2010. Urinary concentrations of cesium were determined by inductively coupled plasma mass spectrometry. Interviews were conducted by face-to-face to obtain information on potential breast cancer risk factors. Logistic regression analysis was used to estimate the associations. RESULTS: Creatinine-adjusted levels [median (25th, 75th) ug/g] of cesium in cases and controls were 17.6 (13.1, 24.0) and 19.3 (15.3, 25.7), respectively. After adjustment for potential risk factors, women in the second and highest tertile of cesium showed a decreased risk of breast cancer in a dose-dependent manner as compared with those in the lowest tertile [ORs and 95% CIs: 0.75 (0.46- 1.22) and 0.50 (0.30-0.82), respectively]. This decrease was more evident in women with ER positive or localized clinical stage in an exploratory stratification analysis. CONCLUSIONS: These findings suggest that cesium may have anticancer efficacy and urinary cesium has potential as a biomarker for breast cancer risk assessment.


Asunto(s)
Biomarcadores de Tumor/orina , Neoplasias de la Mama/etiología , Neoplasias de la Mama/orina , Cesio/efectos adversos , Cesio/orina , Neoplasias de la Mama/prevención & control , Estudios de Casos y Controles , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Pronóstico , Medición de Riesgo , Factores de Riesgo , Encuestas y Cuestionarios
9.
Tidsskr Nor Laegeforen ; 134(19): 1855-7, 2014 Oct 14.
Artículo en Noruego | MEDLINE | ID: mdl-25314987

RESUMEN

A female in her forties with advanced incurable rectal cancer presented to our emergency department after loss of consciousness followed by brief myoclonic jerks in her legs. A cerebral MRI was normal. Her electrocardiogram showed a prolonged QTc interval of 596 milliseconds and hypokalemia was present. She had no family history of congenital long QT syndrome or of cardiovascular disease. She was not on any medication apart from having ingested 100 g caesium carbonate over the previous 11 days as an alternative cancer treatment. Caesium chloride is postulated to increase pH and thereby induce apoptosis in cancer cells. In treatment doses caesium competes with potassium for membrane transport proteins in the cardiac cell membrane and in the reabsorption tubuli of the kidneys. A result is hypokalemia shortly after depolarization during the cardiomyocytes' repolarisation phase or delayed post-depolarisation. Torsade de pointes ventricular arrhythmias, ventricular tachycardia, pump failure and death can follow. A few case reports of adverse effects from caesium ingestion have been published, as well as reports on how caesium is used in animal models to induce ventricular tachycardia, but the hazards of caesium ingestion and its long half-life are not well known in the medical care profession or among patients. As this patient's QTc interval normalised slowly to 413 milliseconds 60 days after stopping caesium ingestion, we consider caesium intoxication and convulsive syncope from a self-terminating ventricular tachycardia as the most probable aetiology. The main message from this case is that alternative medicine can have life-threatening side effects.


Asunto(s)
Arritmias Cardíacas/inducido químicamente , Carbonatos/efectos adversos , Cesio/efectos adversos , Hipopotasemia/inducido químicamente , Síndrome de QT Prolongado/inducido químicamente , Neoplasias del Recto/tratamiento farmacológico , Adulto , Arritmias Cardíacas/tratamiento farmacológico , Carbonatos/administración & dosificación , Carbonatos/uso terapéutico , Cesio/administración & dosificación , Cesio/uso terapéutico , Terapias Complementarias/efectos adversos , Electrocardiografía , Femenino , Humanos , Hipopotasemia/tratamiento farmacológico , Síndrome de QT Prolongado/tratamiento farmacológico , Persona de Mediana Edad , Mioclonía/inducido químicamente , Síncope/inducido químicamente
10.
Environ Geochem Health ; 36(6): 1165-90, 2014 12.
Artículo en Inglés | MEDLINE | ID: mdl-24804829

RESUMEN

Radionuclide contamination in terrestrial ecosystems has reached a dangerous level. The major artificial radionuclide present in the environment is (137)Cs, which is released as a result of weapon production related to atomic projects, accidental explosions of nuclear power plants and other sources, such as reactors, evaporation ponds, liquid storage tanks, and burial grounds. The release of potentially hazardous radionuclides (radiocesium) in recent years has provided the opportunity to conduct multidisciplinary studies on their fate and transport. Radiocesium's high fission yield and ease of detection made it a prime candidate for early radio-ecological investigations. The facility setting provides a diverse background for the improved understanding of various factors that contribute toward the fate and transfer of radionuclides in the terrestrial ecosystem. In this review, we summarize the significant environmental radiocesium transfer factors to determine the damaging effects of radiocesium on terrestrial ecosystem. It has been found that (137)Cs can trace the transport of other radionuclides that have a high affinity for binding to soil particles (silts and clays). Possible remedial methods are also discussed for contaminated terrestrial systems. This review will serve as a guideline for future studies of the fate and transport of (137)Cs in terrestrial environments in the wake of the Fukushima Nuclear Power Plant disaster in 2011.


Asunto(s)
Contaminación Radiactiva del Aire , Cesio/efectos adversos , Restauración y Remediación Ambiental/métodos , Ceniza Radiactiva , Contaminantes Radiactivos/efectos adversos , Contaminación Radiactiva del Agua , Contaminación Radiactiva del Aire/efectos adversos , Contaminación Radiactiva del Aire/análisis , Contaminación Radiactiva del Aire/prevención & control , Cesio/análisis , Radioisótopos de Cesio/efectos adversos , Radioisótopos de Cesio/análisis , Ecosistema , Accidente Nuclear de Fukushima , Monitoreo de Radiación , Ceniza Radiactiva/efectos adversos , Ceniza Radiactiva/análisis , Ceniza Radiactiva/prevención & control , Contaminantes Radiactivos/análisis , Contaminación Radiactiva del Agua/efectos adversos , Contaminación Radiactiva del Agua/análisis , Contaminación Radiactiva del Agua/prevención & control
11.
Neuroradiol J ; 26(6): 607-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24355178

RESUMEN

We describe the CT findings in the brain of a woman with pathologically proven elevated levels of blood and tissue cesium. The 42-year-old woman had been receiving cesium chloride as a non-mainstream treatment for metastatic breast carcinoma. She presented to hospital following a seizure, and died 48 hours after admission. A brain CT performed on hospital admission showed a diffuse increase in attenuation of brain parenchyma. Autopsy revealed elevated levels of cesium in blood and solid organs including the brain. We hypothesize that the imaging findings are attributable to the abnormally elevated level of brain cesium at the time of the CT scan. To our knowledge, this is the first reported case of this imaging finding.


Asunto(s)
Antineoplásicos/efectos adversos , Encéfalo/diagnóstico por imagen , Cesio/análisis , Cloruros/efectos adversos , Adulto , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/secundario , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/secundario , Cesio/efectos adversos , Femenino , Humanos , Tomografía Computarizada por Rayos X
12.
PLoS One ; 8(8): e72143, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23967281

RESUMEN

Although two major breast cancer susceptibility genes, BRCA1 and BRCA2, have been identified accounting for 20% of breast cancer genetic risk, identification of other susceptibility genes accounting for 80% risk remains a challenge due to the complex, multi-factorial nature of breast cancer. Complexity derives from multiple genetic determinants, permutations of gene-environment interactions, along with presumptive low-penetrance of breast cancer predisposing genes, and genetic heterogeneity of human populations. As with other complex diseases, dissection of genetic determinants in animal models provides key insight since genetic heterogeneity and environmental factors can be experimentally controlled, thus facilitating the detection of quantitative trait loci (QTL). We therefore, performed the first genome-wide scan for loci contributing to radiation-induced mammary tumorigenesis in female F2-(Dahl S x R)-intercross rats. Tumorigenesis was measured as tumor burden index (TBI) after induction of rat mammary tumors at forty days of age via ¹²7Cs-radiation. We observed a spectrum of tumor latency, size-progression, and pathology from poorly differentiated ductal adenocarcinoma to fibroadenoma, indicating major effects of gene-environment interactions. We identified two mammary tumorigenesis susceptibility quantitative trait loci (Mts-QTLs) with significant linkage: Mts-1 on chromosome-9 (LOD-2.98) and Mts-2 on chromosome-1 (LOD-2.61), as well as two Mts-QTLs with suggestive linkage: Mts-3 on chromosome-5 (LOD-1.93) and Mts-4 on chromosome-18 (LOD-1.54). Interestingly, Chr9-Mts-1, Chr5-Mts-3 and Chr18-Mts-4 QTLs are unique to irradiation-induced mammary tumorigenesis, while Chr1-Mts-2 QTL overlaps with a mammary cancer susceptibility QTL (Mcs 3) reported for 7,12-dimethylbenz-[α]antracene (DMBA)-induced mammary tumorigenesis in F2[COP x Wistar-Furth]-intercross rats. Altogether, our results suggest at least three distinct susceptibility QTLs for irradiation-induced mammary tumorigenesis not detected in genetic studies of chemically-induced and hormone-induced mammary tumorigenesis. While more study is needed to identify the specific Mts-gene variants, elucidation of specific variant(s) could establish causal gene pathways involved in mammary tumorigenesis in humans, and hence novel pathways for therapy.


Asunto(s)
Carcinogénesis/efectos de la radiación , Sitios Genéticos , Hibridación Genética , Neoplasias Mamarias Experimentales/genética , Neoplasias Mamarias Experimentales/patología , Neoplasias Inducidas por Radiación/genética , Neoplasias Inducidas por Radiación/patología , Animales , Carcinogénesis/genética , Cesio/efectos adversos , Femenino , Predisposición Genética a la Enfermedad/genética , Genómica , Humanos , Masculino , Sitios de Carácter Cuantitativo/genética , Ratas
13.
J Clin Pharm Ther ; 38(3): 254-7, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23489152

RESUMEN

WHAT IS KNOWN AND OBJECTIVE: Complementary medicines are commonly used by many patients. Caesium, a complementary therapy said to be of benefit for cancer treatment, has been associated with cardiac arrhythmias in the literature. We report a case of caesium-induced torsades de pointes and provide an evidence review. CASE SUMMARY: A 46-year-old woman with syncope experienced torsades de pointes and cardiac arrest. Upon admission her QTc was 620 ms. The patient had taken caesium carbonate 10 g daily for 1 month prior to admission. The patient was successfully resuscitated and discharged home after 35 days in hospital. WHAT IS NEW AND CONCLUSION: Ten cases of caesium-induced cardiac arrhythmias have previously been reported in the literature. Treatment strategies differed significantly among the cases. However, all patients recovered from the event. Complementary and alternative medicines should not be overlooked as a potential cause of serious adverse events.


Asunto(s)
Carbonatos/efectos adversos , Cesio/efectos adversos , Terapias Complementarias/efectos adversos , Torsades de Pointes/inducido químicamente , Carbonatos/uso terapéutico , Cesio/uso terapéutico , Femenino , Humanos , Persona de Mediana Edad
14.
Can J Cardiol ; 25(9): e329-31, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19746253

RESUMEN

The chloride salt of cesium, a group 1A element, is gaining popularity as an alternative treatment of advanced cancers. Cesium chloride has primarily been used in cardiovascular research for arrhythmogenesis in animals because of its potassium-blocking effects. The present report describes a 45-year-old woman with metastatic breast cancer who experienced repeated episodes of torsades de pointes polymorphic ventricular tachycardia after several months of oral cesium therapy. There was a clear temporal relationship between cesium ingestion and the arrhythmia, which later resolved following discontinuation of cesium therapy. Serial cesium plasma and whole blood levels were measured over the ensuing six months and pharmacokinetic analysis was performed.


Asunto(s)
Cesio/efectos adversos , Cloruros/efectos adversos , Electrocardiografía/efectos de los fármacos , Torsades de Pointes/inducido químicamente , Antiarrítmicos/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Cesio/uso terapéutico , Cloruros/uso terapéutico , Femenino , Estudios de Seguimiento , Frecuencia Cardíaca/fisiología , Humanos , Persona de Mediana Edad , Torsades de Pointes/tratamiento farmacológico , Torsades de Pointes/fisiopatología
15.
Pharmacotherapy ; 28(8): 1059-65, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18657021

RESUMEN

Alternative medicine is becoming increasingly popular, especially with terminally ill patients. Most alternative remedies have not been adequately studied or proven effective for the diseases for which they are promoted. In the worst cases, these therapies are harmful. We describe a 16-year-old girl with metastatic hepatocellular carcinoma who experienced cesium-induced QT-interval prolongation after the start of a cesium chloride-based alternative treatment regimen. She had received seven courses of chemotherapy, with a cumulative doxorubicin dose of 500 mg/m(2) over 5 months, resulting in minimal tumor regression. Against the advice of her oncologist, she abandoned traditional therapy and started an alternative regimen that included cesium chloride supplements. Two weeks later, the patient went to a local emergency department after experiencing two brief syncopal episodes. An electrocardiogram revealed occasional premature ventricular contractions, a QTc interval of 683 msec (normal range for females 450-460 msec), and R on T phenomenon. She was admitted to the hospital and later experienced monomorphic ventricular tachycardia, which resolved spontaneously. Lidocaine therapy was started, and the patient was transferred to a cardiac intensive care unit at our hospital. Her plasma cesium level was 2400 microg/dl (normal < 1 microg/dl), and her family was told to stop her alternative treatment regimen. On hospital day 5, as no additional arrhythmias had occurred, lidocaine was discontinued. Two days later, the patient's QTc interval had decreased to 546 msec, and she was discharged home. Two months later, at a follow-up visit, her serum cesium level was 1800 microg/dl, and her QTc interval was 494 msec. According to the Naranjo adverse drug reaction probability scale, cesium was the probable cause of the patient's arrhythmia. In animal models, cesium chloride has induced cardiac arrhythmias, including torsade de pointes. It inhibits delayed rectifier potassium channels in the myocardium, causing delayed repolarization and QT-interval prolongation. Patients with cancer should be aware that alternative remedies may be harmful and ineffective. Because patients may be unlikely to self-report alternative remedies, health care providers should specifically ask their patients about any alternative treatments they may be taking and should be knowledgeable about their toxicities.


Asunto(s)
Cesio/efectos adversos , Cloruros/efectos adversos , Electrocardiografía/efectos de los fármacos , Adolescente , Carcinoma Hepatocelular/tratamiento farmacológico , Femenino , Humanos , Neoplasias Hepáticas/tratamiento farmacológico
17.
Paediatr Anaesth ; 16(4): 471-8, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16618306

RESUMEN

We present the case of a child who had had a previous episode of torsades de pointes (TdP) and who was scheduled for elective surgery under general anesthesia. The pathophysiology of this condition and the anesthesia concerns are discussed. An 8-year-old male with a history of osteogenic sarcoma had undergone an uneventful limb salvage procedure 2 years earlier. During a subsequent admission to the hospital, he had had a cardiopulmonary arrest with complete recovery. Telemetry electrocardiogram (ECG) rhythm recordings obtained during the event showed TdP that degenerated into ventricular fibrillation, which then terminated spontaneously. On a subsequent ECG, the QTc interval was 694 ms. The prolonged QT interval was attributed to homeopathic use of cesium chloride supplements and the QT interval normalized after cesium was stopped. He presented for an elective procedure and, with an anesthetic plan that emphasized medications without known effect on the QT interval, had an uneventful perioperative course. The optimal anesthesia plan for patients with prolonged QT or those suspected to be at risk for prolongation of the QT interval has not been well described. Available evidence suggests that using total intravenous anesthesia with propofol may be the safest and was used uneventfully in this case. Additionally, this case emphasizes the need to inquire about the use of supplements and naturopathic medications, even in children, that may have life-threatening side effects or interactions with anesthetic agents.


Asunto(s)
Anestesia General , Síndrome de QT Prolongado/complicaciones , Cesio/efectos adversos , Niño , Sedación Consciente , Procedimientos Quirúrgicos Electivos , Electrocardiografía , Paro Cardíaco/etiología , Homeopatía , Humanos , Síndrome de QT Prolongado/fisiopatología , Masculino , Cuidados Preoperatorios , Telemetría , Torsades de Pointes/complicaciones , Fibrilación Ventricular/fisiopatología
18.
Med Tr Prom Ekol ; (3): 36-40, 2004.
Artículo en Ruso | MEDLINE | ID: mdl-15124394

RESUMEN

The article deals with consequences seen in track driver after prolonged exposure to radiation caused by "lost" gamma-source (cesium-137) that long remained in receptacle of the vehicle's left door. Radiation dose averaged 8 Gy. The authors presented clinical manifestations, changes in peripheral blood and bone marrow, cytogenetic data by progression of radiation hemopoiesis hypoplasy to myelodysplastic syndrome and to acute leukaemia.


Asunto(s)
Conducción de Automóvil , Cesio/efectos adversos , Rayos gamma/efectos adversos , Leucemia/etiología , Enfermedades Profesionales/etiología , Traumatismos por Radiación/complicaciones , Adulto , Anciano , Anciano de 80 o más Años , Enfermedad Crónica , Resultado Fatal , Femenino , Encefalopatía Hepática , Humanos , Masculino , Persona de Mediana Edad
19.
Belo Horizonte; s.n; 2003. 113 p. ilus, tab, graf.
Tesis en Portugués | LILACS, BDENF - Enfermería | ID: lil-407386

RESUMEN

Pesquisa descritiva de caráter exploratório, que se fundamenta na hipótese de que a exposição individual ou familiar ao acidente radiológico com o Césio137, ocorrido em Goiânia, Goiás, em 1987, e aos fatores a ele relacionados decorrentes da situação de estresse, ansiedade e depressão tanto individual como familiar, possam ter desencadeado nestas pessoas transtornos mentais, índices mais elevados do que os registrados na população em geral...


Asunto(s)
Humanos , Liberación de Radiactividad Peligrosa , Trastornos Mentales , Cesio/efectos adversos , Brasil , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA